Purpose of an extended role in ADHD
This framework serves as a guide for General Practitioners (GPs) seeking to expand their role in providing care for individuals with attention deficit hyperactivity disorder (ADHD). Referred to as "GPwER ADHD", this role operates within a comprehensive care model, with an interdisciplinary, patient-centric approach.
It may help to read the RCGP definition of a GP.
The purpose of establishing a GPwER ADHD is multifaceted. Primarily, it aims to enhance the quality of care and support provided to individuals with ADHD, a neurodevelopmental disorder that significantly impacts daily functioning.
In addition, by designating GPs with specialised expertise, patients can access more comprehensive, tailored, and efficient healthcare services by creating a role where a GPwER ADHD can better meet the increasing demand for ADHD-related care through:
- Early recognition
- Comprehensive assessments including comorbidities
- Diagnosis
- Treatment
- Ongoing management
- Holistic support
This role aims to improve overall healthcare outcomes for patients by promoting early identification and early intervention, thus reducing the negative functional impact ADHD often has on various aspects of life, including education, work, relationships, and overall wellbeing (Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study).
Acknowledgements
We would like to thank the following for their work in support of the development of this framework: Dr Heidi Phillips, Dr Georgina Brown, Dr Chris Schramm, Dr Elizabeth Stonell, and Dr Sarah Michaels.
In addition, we would like to thank Dr Peter Mason, Consultant Psychiatrist / ADHD Specialist and Trustee of the ADHD Foundation for his review of the Framework.
Framework review
If you notice any inaccuracies in the framework, or have comments or suggestions on any of the content, please let the professional standards team know by emailing professionalstandards@rcgp.org.uk.
Approved framework
Date the framework was approved: March 2024.
Next review
Date for next review: March 2027.